Jason K. Yokoyama
Medpace (United States)(US)TRIA Bioscience (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Glioma Diagnosis and Treatment, Viral Infectious Diseases and Gene Expression in Insects, Immunotherapy and Immune Responses, Advanced Electron Microscopy Techniques and Applications
Most-Cited Works
- → Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis(2021)297 cited
- → Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety(2022)246 cited
- → Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses(2020)80 cited
- → CD22 CAR Optimization for Improved in-Human Activity Following Inadequate CD22 CAR Activity in Phase 1 Clinical Trial PLAT-04(2021)9 cited
- → Abstract LB-109: Adaptor controlled CAR-T cell immunotherapy for treatment of folate receptor-alpha/beta positive solid and liquid tumors(2018)2 cited
- → Abstract A032: Chimeric antigen receptor (CAR) targeted epitope determines optimal CAR spacer length for therapy against medulloblastoma(2019)2 cited
- → A novel preclinical immunocompetent CAR T cell mouse model for solid tumors(2019)1 cited
- → 1085 OPB-101: a mesothelin-specific CAR T cell therapy leveraging protein design to enhance T cell proliferation and persistence for the treatment of ovarian cancer(2024)1 cited
- → 185 Tuning the cell-cell distance via the non-signaling extracellular spacer domain of chimeric antigen receptors is critical for optimal activity(2022)
- → Supplementary Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety(2023)